99 related articles for article (PubMed ID: 24903215)
1. Serum selenium deficiency in patients with hematological malignancies: is a supplementation study mandatory?
Muecke R; Micke O; Schomburg L; Buentzel J; Adamietz IA; Huebner J;
Acta Haematol; 2014; 132(2):256-8. PubMed ID: 24903215
[No Abstract] [Full Text] [Related]
2. Phase I-II study of high-dose busulfan and cyclophosphamide followed by autologous peripheral blood stem cell transplantation for hematological malignancies: toxicities and hematopoietic recovery.
Ballester OF; Agaliotis DP; Hiemenz JW; Janssen WE; Fields KK; Zorksy PE; Goldstein SC; Perkins JB; Elfenbein GJ
Bone Marrow Transplant; 1996 Jul; 18(1):9-14. PubMed ID: 8831989
[TBL] [Abstract][Full Text] [Related]
3. Idarubicin-intensified BUCY2 regimens may lower relapse rate and improve survival in patients undergoing allo-SCT for high-risk hematological malignancies: a retrospective analysis.
Hong M; Wu Q; Hu C; Fang J; You Y; Zhong Z; Zou P; Hu Y; Xia L
Bone Marrow Transplant; 2012 Feb; 47(2):196-202. PubMed ID: 21441957
[TBL] [Abstract][Full Text] [Related]
4. Fourteenth biannual report of the Cochrane Haematological Malignancies Group--focus on autologous stem cell transplantation in hematological malignancies.
Rancea M; Skoetz N; Monsef I; Hübel K; Engert A; Bauer K
J Natl Cancer Inst; 2012 Jul; 104(14):NP. PubMed ID: 22825560
[No Abstract] [Full Text] [Related]
5. Biosimilar G-CSF (filgrastim) is effective for peripheral blood stem cell mobilization and non-cryopreserved autologous transplantation.
Yafour N; Brahimi M; Osmani S; Arabi A; Bouhass R; Bekadja MA
Transfus Clin Biol; 2013 Dec; 20(5-6):502-4. PubMed ID: 23916573
[No Abstract] [Full Text] [Related]
6. Reduced toxicity conditioning and allogeneic stem cell transplantation in adults using fludarabine, carmustine, melphalan, and antithymocyte globulin: outcomes depend on disease risk index but not age, comorbidity score, donor type, or human leukocyte antigen mismatch.
Slack JL; Dueck AC; Fauble VD; Sproat LO; Reeder CB; Noel P; Khera N; Betcher JA; Klein JL; Leis JF; Adams RH
Biol Blood Marrow Transplant; 2013 Aug; 19(8):1167-74. PubMed ID: 23664940
[TBL] [Abstract][Full Text] [Related]
7. Impact of lymphocyte and monocyte recovery on the outcomes of allogeneic hematopoietic SCT with fludarabine and melphalan conditioning.
DeCook LJ; Thoma M; Huneke T; Johnson ND; Wiegand RA; Patnaik MM; Litzow MR; Hogan WJ; Porrata LF; Holtan SG
Bone Marrow Transplant; 2013 May; 48(5):708-14. PubMed ID: 23103674
[TBL] [Abstract][Full Text] [Related]
8. [Hematopoietic stem cell transplantation for hematological malignancies].
Zhong MZ; Chen FP; Shu YG
Hunan Yi Ke Da Xue Xue Bao; 2002 Jun; 27(3):242-4. PubMed ID: 12575304
[TBL] [Abstract][Full Text] [Related]
9. Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies.
De Fabritiis P; Dentamaro T; Picardi A; Cudillo L; Masi M; Amadori S
Haematologica; 2004 Feb; 89(2):243-5. PubMed ID: 15003905
[No Abstract] [Full Text] [Related]
10. Oral glutamine supplements in autologous hematopoietic transplant: impact on gastrointestinal toxicity and plasma protein levels.
Canovas G; León-Sanz M; Gómez P; Valero MA; Gomis P; La Huerta JJ
Haematologica; 2000 Nov; 85(11):1229-30. PubMed ID: 11064482
[No Abstract] [Full Text] [Related]
11. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications.
Steingrimsdottir H; Gruber A; Björkholm M; Svensson A; Hansson M
Haematologica; 2000 Aug; 85(8):832-8. PubMed ID: 10942930
[TBL] [Abstract][Full Text] [Related]
12. Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation.
Bacigalupo A; Sormani MP; Lamparelli T; Gualandi F; Occhini D; Bregante S; Raiola AM; di Grazia C; Dominietto A; Tedone E; Piaggio G; Podesta M; Bruno B; Oneto R; Lombardi A; Frassoni F; Rolla D; Rollandi G; Viscoli C; Ferro C; Garbarino L; Van Lint MT
Haematologica; 2004 Oct; 89(10):1238-47. PubMed ID: 15477210
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte colony-stimulating factor after autologous CD34+ immunoselected peripheral blood stem cell transplantation.
Piccirillo N; De Matteis S; Sorà F; d'Onofrio G; Leone G; Sica S
Haematologica; 2004 Sep; 89(9):1144-6. PubMed ID: 15377480
[TBL] [Abstract][Full Text] [Related]
14. Third biannual report of the Cochrane Haematological Malignancies Group.
Kober T; Skoetz N; Trelle S; Bohlius J; Engert A;
J Natl Cancer Inst; 2005 Aug; 97(16):E2. PubMed ID: 16106014
[No Abstract] [Full Text] [Related]
15. Effect of Brazil nut supplementation on plasma levels of selenium in hemodialysis patients: 12 months of follow-up.
Stockler-Pinto MB; Lobo J; Moraes C; Leal VO; Farage NE; Rocha AV; Boaventura GT; Cozzolino SM; Malm O; Mafra D
J Ren Nutr; 2012 Jul; 22(4):434-9. PubMed ID: 22217537
[TBL] [Abstract][Full Text] [Related]
16. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
Nguyen MH; Leather H; Clancy CJ; Cline C; Jantz MA; Kulkarni V; Wheat LJ; Wingard JR
Biol Blood Marrow Transplant; 2011 Jul; 17(7):1043-50. PubMed ID: 21087680
[TBL] [Abstract][Full Text] [Related]
17. Comparison of infectious complications during induction/consolidation chemotherapy versus allogeneic hematopoietic stem cell transplantation.
Orasch C; Weisser M; Mertz D; Conen A; Heim D; Christen S; Gratwohl A; Battegay M; Widmer A; Flückiger U
Bone Marrow Transplant; 2010 Mar; 45(3):521-6. PubMed ID: 19668238
[TBL] [Abstract][Full Text] [Related]
18. Peripheral blood stem cell (PBSC) mobilization with chemotherapy followed by sequential IL-3 and G-CSF administration in extensively pretreated patients.
Kolbe K; Peschel C; Rupilius B; Després D; Burger K; Sklenar I; Färber L; Huber C; Derigs HG
Bone Marrow Transplant; 1997 Dec; 20(12):1027-32. PubMed ID: 9466274
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing haemopoietic recovery following chemotherapy-mobilised autologous peripheral blood progenitor cell transplantation for haematological malignancies: a retrospective analysis of a 10-year single institution experience.
Lowenthal RM; Fabères C; Marit G; Boiron JM; Cony-Makhoul P; Pigneux A; Agape P; Vezon G; Bouzgarou R; Dazey B; Fizet D; Bernard P; Lacombe F; Reiffers J
Bone Marrow Transplant; 1998 Oct; 22(8):763-70. PubMed ID: 9827973
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of transplantation material based on immunophenotype and in vitro clonogenic assays of hematopoietic stem and progenitor cells].
Balana-Nowak A; Zdziłowska E; Szostek M; Skotnicki AB
Przegl Lek; 1999; 56 Suppl 1():28-33. PubMed ID: 10494179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
